Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen, Inc. | -0.15% | 247.72 | 1.3% | $844.18m | |
| MRNA | Moderna, Inc. | 2.92% | 69.87 | 0.0% | $763.28m | |
| NVAX | Novavax, Inc. | -6.19% | 108.36 | 96.5% | $693.95m | |
| IMMU | Immunomedics, Inc. | 0.22% | 85.53 | 11.0% | $600.97m | |
| GILD | Gilead Sciences, Inc. | 0.02% | 65.05 | 1.0% | $599.14m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.73% | 555.24 | 2.7% | $445.10m | |
| BIIB | Biogen, Inc. | -0.32% | 274.48 | 1.6% | $332.97m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -2.24% | 265.39 | 1.9% | $329.17m | |
| ILMN | Illumina, Inc. | -0.85% | 295.50 | 3.5% | $313.09m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.53% | 9.43 | 1.5% | $274.82m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.36% | 113.72 | 2.0% | $266.55m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 1.30% | 79.38 | 4.3% | $239.49m | |
| MNTA | Momenta Pharmaceuticals, Inc. | -0.13% | 52.26 | 3.0% | $237.34m | |
| VXRT | Vaxart, Inc. | 3.01% | 8.22 | 0.0% | $213.57m | |
| SGEN | Seattle Genetics, Inc. | 3.01% | 180.94 | 6.0% | $194.15m |
Company Profile
Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Cambridge, MA.